Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Strongyloidiasis

Strongyloidiasis is a human parasitic disease caused by the nematode Strongyloides stercoralis. Other Strongyloides include S. fülleborni, which infects chimpanzees and baboons and may produce limited infections in humans. (From the Wikpedia article Strongyloidiasis.)

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Strongyloidiasis:

Pubmed Logo
Prevention of strongyloides hyperinfection syndrome: a rheumatological point of view.
BACKGROUND: Strongyloides stercoralis (S.stercoralis) is a parasite that...
7th November, 2009
Escola Bahiana de Medicina e Saude Publica, Salvador, Bahia, Brazil. Eur J Intern Med. 2009 Dec;20(8):744-8. Epub 2009 Sep 27.
DOI Direct Link
Strongyloides stercoralis and the immune response.
The immune system is a highly evolved network of cells and molecules that...
7th November, 2009
Department of Medical Microbiology & Parasitology, College of Medicine of Parasitol Int. 2009 Nov 3.
DOI Direct Link
Screening practices for infectious diseases among Burmese refugees in Australia.
Increasing numbers of refugees from Burma (Myanmar) are resettling in...
7th November, 2009
Royal Melbourne Hospital, Parkville, Victoria 3050, Australia. Emerg Infect Dis. 2009 Nov;15(11):1769-72.
Disseminated strongyloidiasis caused by heart donor-to-host transmission presenting with purpura.
Increasing numbers of refugees from Burma (Myanmar) are resettling in...
6th November, 2009
Department of Dermatology, University Medical Center Groningen, PO Box Clin Exp Dermatol. 2009 Nov 3.
DOI Direct Link
Intestinal parasitic infections in relation to HIV/AIDS status, diarrhea and CD4 T-cell count.
BACKGROUND: HIV infection has been modifying both the epidemiology and...
5th November, 2009
Department of Medical Laboratory Science, Gondar University, PO Box 196 BMC Infect Dis. 2009 Sep 18;9:155.
DOI Direct Link

View more research publications.

Strongyloidiasis Clinical Trials:

Clinical Trials Logo
Ivermectin Versus Albendazole for Chronic Strongyloidiasis

Strongyloidiasis Patents:

USPTO Logo
US Patent No.Title
7247725 Gamma-aminoamide modulators of chemokine receptor activity
7354932 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
7354934 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
7378409 Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity
7381738 Substituted bicycloalkylamine derivatives as modulators of chemokine receptor activity

View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Strongyloidiasis scientists - we have details of around 281 individuals working on Strongyloidiasis .


This page has been viewed 331 times
Recent Search Terms used to find this page: strongyloides 2009 information | strongyloides 2009 | strongyloides breast milk | strongyloidiasis | strongyloidiasis | strongyloides 2009 | Strongyloides endemic | strongyloidiasis | strongyloidiasis | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Strongyloidiasis across BioPortfolio, or for Strongyloidiasis Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.